In the press
New Podcast Launched
We are ecstatic to announce that we have launched our new podcast “OGB Podcast” on both Spotify and Anchor.
We will be talking to industry leaders about the state of the biotech industry as well as delving into the specifics of our guests expertise. You can find and listen to us on Spotify ( https://open.spotify.com/show/0tSRtB4tFUcqHhW43RkWIL ) as well as Anchor ( https://anchor.fm/marc-appel9 ).
Related Press
The University of Pittsburgh and Orange Grove Bio Establish Partnership …
The University of Pittsburgh and Orange Grove Bio Establish Partnership… The following excerpt was taken from Globe Newswire — continue reading here. Orange Grove Bio, a preclinical drug investment and development firm, and the University of Pittsburgh today announced the establishment of a collaboration “Orange Grove Bio, a preclinical drug investment and development firm, and… Continue reading The University of Pittsburgh and Orange Grove Bio Establish Partnership …
Leading Korean VC partners with USA’s Orange Grove
Orange Grove Bio, a USA-based pre-clinical drug investment and development firm, and SV Investment, a South Korea-based venture capital and private equity firm, today announced the establishment of a new partnership through which the companies will collaborate on jointly sourcing and developing novel therapeutics in the USA and Korea. As priority partners, the companies will cultivate the US and Korean biotech landscape through technology licensing and company creation in their respective geographic areas.
Under terms of the partnership, SV Investment will leverage its relationships with biotech companies and academic institutions in Korea to identify licensing opportunities for promising early-stage research in the area of drug development. As part of the agreement, Marc Appel, chief executive of Orange Grove, will join SV Investment as a venture partner and will play a key role in evaluating the licensing opportunities that are identified at Korean biotech companies and universities. As appropriate, Orange Grove will work to license these technologies as a basis for life science company creation in the USA, with SV Investment serving as an early-stage investor in the companies.
IF HENRY FORD WERE IN BIOTECH
IF HENRY FORD WERE IN BIOTECH Please join us to hear from our CEO, Marc Appel.
How to Invest in Biotech Series – Phases, Stages, and Pitfalls
Emily Whitehead was 5 years old when she was diagnosed with acute lymphoblastic leukemia… Her cancer was resistant to traditional treatments and her prognosis was poor. In a final effort to save their daughter, her parents enrolled her in a clinical trial study at Children’s Hospital of Philadelphia for a new type of therapy called… Continue reading How to Invest in Biotech Series – Phases, Stages, and Pitfalls
Upcoming Webinar for Pre-Clinical Biotech Development Opportunities on April 16th at 1 PM EST.
Upcoming Webinar for Pre-Clinical Biotech Development Opportunities on April 16th at 1 PM EST. Please join us to hear from our CEO, Marc Appel.– continue reading here. Upcoming Webinar for Pre-Clinical Biotech Development Opportunities
Orange Grove Bio and Cincinnati Children’s Hospital Medical Center Establish Collaboration
Orange Grove Bio, a preclinical drug investment and development firm, and Cincinnati
Cincinnati’s ‘innovation district’ lures biotech HQ from New York City area
Cincinnati’s ‘innovation district’ lures biotech HQ from New York City area The following excerpt was taken from Cincinnati Enquirer — continue reading here. Orange Grove Bio, a venture capital firm that invests mainly in therapeutic drug companies, is moving its headquarters from the New York City “Orange Grove Bio, a venture capital firm that invests… Continue reading Cincinnati’s ‘innovation district’ lures biotech HQ from New York City area
Cronicle Tech News
Cronicle Tech News The following was taken from the Cronicle written by Lauren K. Cowan. Check out the original piece here: https://cronicle.press/2021/03/08/ann-arbors-asalyxa-bio-raises-2-million-to-start-clinical-trials-for-neutrophil-targeting-drug-delivery-tech/ Research Bridge Partners – a 501 (c) (3) organization that bridges preeminent innovators at mid-continent research universities Asalyxa Bio, Inc., a biopharmaceutical startup developing nano-engineered, immune cell-targeted therapeutics, just announced the closing of… Continue reading Cronicle Tech News
Wall Street Journal
Wall Street Journal The following was taken from the Wall Street Journal. Check out the original piece here: https://www.wsj.com/articles/vc-daily-biotechs-test-new-company-building-model-11614261635 We are incredibly excited and humbled to be recognized in the Wall Street Journal for our innovative business model! We thank everyone who has been supporting us from the beginning.